Pagas, Rodrigo S.

HRN: 24-78-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/02/2025
04/08/2025
IV
675mg
Q24
Impending Acute Respiratory Failuresec To CAP MR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: